2021 Q2 Form 10-Q Financial Statement
#000121390021050599 Filed on September 29, 2021
Income Statement
| Concept | 2021 Q2 | 2020 Q2 |
|---|---|---|
| Revenue | $0.00 | |
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | ||
| YoY Change | ||
| % of Gross Profit | ||
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | ||
| YoY Change | ||
| % of Gross Profit | ||
| Operating Expenses | $3.290K | |
| YoY Change | ||
| Operating Profit | -$3.285K | |
| YoY Change | ||
| Interest Expense | ||
| YoY Change | ||
| % of Operating Profit | ||
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | -$3.285K | |
| YoY Change | ||
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$3.285K | |
| YoY Change | ||
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$151.20 | |
| COMMON SHARES | ||
| Basic Shares Outstanding | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2021 Q2 | 2020 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $36.17K | |
| YoY Change | ||
| Cash & Equivalents | $36.17K | |
| Short-Term Investments | ||
| Other Short-Term Assets | $26.80K | |
| YoY Change | ||
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $62.97K | |
| YoY Change | ||
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | ||
| YoY Change | ||
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $294.6K | |
| YoY Change | ||
| Total Long-Term Assets | $294.6K | |
| YoY Change | ||
| TOTAL ASSETS | ||
| Total Short-Term Assets | $62.97K | |
| Total Long-Term Assets | $294.6K | |
| Total Assets | $357.6K | |
| YoY Change | ||
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $40.00 | |
| YoY Change | ||
| Accrued Expenses | $79.26K | |
| YoY Change | ||
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $263.3K | |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $342.6K | |
| YoY Change | ||
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | |
| YoY Change | ||
| Other Long-Term Liabilities | ||
| YoY Change | ||
| Total Long-Term Liabilities | $0.00 | |
| YoY Change | ||
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $342.6K | |
| Total Long-Term Liabilities | $0.00 | |
| Total Liabilities | $342.6K | |
| YoY Change | ||
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | $0.00 | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $14.94K | |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $357.6K | |
| YoY Change |
Cashflow Statement
| Concept | 2021 Q2 | 2020 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$3.285K | |
| YoY Change | ||
| Depreciation, Depletion And Amortization | ||
| YoY Change | ||
| Cash From Operating Activities | -$3.240K | |
| YoY Change | ||
| INVESTING ACTIVITIES | ||
| Capital Expenditures | ||
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | ||
| YoY Change | ||
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $0.00 | |
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -2.670K | |
| YoY Change | ||
| NET CHANGE | ||
| Cash From Operating Activities | -3.240K | |
| Cash From Investing Activities | ||
| Cash From Financing Activities | -2.670K | |
| Net Change In Cash | -5.910K | $0.00 |
| YoY Change | ||
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$3.240K | |
| Capital Expenditures | ||
| Free Cash Flow | ||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001841425 | ||
| CY2021Q2 | cenqu |
Common Stock Value1
CommonStockValue1
|
431 | USD |
| CY2020Q4 | cenqu |
Common Stock Value1
CommonStockValue1
|
431 | USD |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
3750000 | shares |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
3750000 | shares | |
| CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
USD | |
| CY2020Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
USD | |
| CY2021Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2021Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
| CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
| CY2021Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
| CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
| CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
USD | |
| CY2020Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
3750000 | shares |
| CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
USD | |
| CY2020Q2 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
USD | |
| us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
USD | ||
| CY2020Q2 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
USD | |
| CY2020Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
USD | ||
| CY2020Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
USD | |
| CY2020Q2 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
USD | |
| CY2020Q2 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
USD | |
| CY2020Q2 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
USD | |
| CY2020Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
USD | |
| CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
USD | |
| CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
USD | |
| CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
USD | |
| CY2020Q2 | cenqu |
Deferred Offering Costs Paid By Sponsor Under Promissory Note
DeferredOfferingCostsPaidBySponsorUnderPromissoryNote
|
USD | |
| CY2020Q2 | cenqu |
Accrued Deferred Offering Costs
AccruedDeferredOfferingCosts
|
USD |
